Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
With a poor return of value, and a huge overhead for research, patents are a bad investment for the academy, this article argues.
In an unexpected lawsuit, US federal officials claim that Gilead Sciences willfully disregarded government patents on medicines necessary to end the AIDS epidemic.
A new study of millions of patents granted between 1926 and 2017 supports the value of spending tax dollars on basic research.